Vertex Pharma scientist talks about the long road to developing non
Time:2024-05-22 10:47:12 Source:styleViews(143)
WASHINGTON (AP) — For decades, patients seeking medication for pain have had two choices: over-the-counter drugs like aspirin or powerful prescription opioids like oxycodone.
Opioid prescriptions have plummeted over the last decade as doctors have become more attuned to the risks of addiction and misuse during the country’s ongoing drug epidemic.
Vertex Pharmaceuticals recently reported positive results for a non-opioid painkiller, one of several medications the Boston-based drugmaker has been developing for various forms of pain. Patients taking the drug after surgery experienced more pain relief than those getting a placebo, although the drug didn’t meet a secondary goal of outperforming treatment with an opioid.
The Associated Press spoke with Vertex’s chief scientist Dr. David Altshuler about the company’s research and development plans. The interview has been edited for length and clarity.
Previous:Election 2024: Nikki Haley faces a key decision on whether or not to endorse Trump
Next:Germany and Real Madrid great Toni Kroos to retire after Euro 2024
You may also like
- Georgia QB Jaden Rashada sues Florida coach, others over failed $14M NIL deal
- Christopher Luxon tells team to fact
- Ghahraman back in New Zealand amid shoplifting claims
- Auckland rail crossings to be removed ahead of City Rail Link opening
- Germany and Real Madrid great Toni Kroos to retire after Euro 2024
- Calls to get e
- Sinead O'Connor died of natural causes, London coroner says
- Te Pūkenga to be replaced with 8
- Testimony at Sen. Bob Menendez's bribery trial focuses on his wife's New Jersey home